Charlie SRL
Charlie reported total assets of 106,397 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jun 2026).
The score of Charlie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -1 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Charlie's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 43,193 € | ||||
| Equity | 75,204 € | ||||
| Cash | 97,307 € | ||||
| EBITDA | 55,755 € | ||||
| Total assets | 106,397 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jun 2026
- Year ended 31 Dec 2024filed on 27 May 2025
- Year ended 31 Dec 2023filed on 27 May 2024
- Year ended 31 Dec 2022filed on 14 Jun 2023
- Year ended 31 Dec 2021filed on 31 May 2022
Charlie's financial analysis
- Solvency70.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Charlie
Charlie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0699.692.573
- VAT number
- BE0699692573
- Peppol
- Registered · 0208:0699692573 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jul 2018
- Registered office
- 2470 Retie
- Latest accounts
- 2025 · filed on 03 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Charlie (SRL) has been based in Retie since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 43,193 € and equity of 75,204 €; its revenue is not published. Its solvency stands at 70.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Charlie
Companies in the same business, of comparable size and area, outside its group.
- Caroline Vandierendonck Retail sale of pharmaceutical products Bree · balance sheet 115,934 €
- Jeûne & Hormèse Retail sale of pharmaceutical products Chaudfontaine · balance sheet 27,054 €
- Phardep Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 117,517 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- ELI Retail sale of pharmaceutical products Genk · balance sheet 53,448 €
- OKINEO System Retail sale of pharmaceutical products Colfontaine · balance sheet 64,459 €
- Pharmacie Marievoet Retail sale of pharmaceutical products Auderghem · balance sheet 60,288 €
- Montpharma Retail sale of pharmaceutical products Forest · balance sheet 135,487 €
Frequently asked questions about Charlie
What is the revenue of Charlie?
Charlie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Charlie?
In Belgium, the VAT number is the company number prefixed with BE: BE0699692573 for Charlie, if the company is VAT-registered. Its company number (CBE) is 0699.692.573.
Where is the registered office of Charlie?
According to the CBE register, the registered office of Charlie is in 2470 Retie.
What is the equity of Charlie?
At the close of the 2025 financial year, the equity of Charlie amounts to 75,204 €, a solvency of 70.7% of total assets.
Who manages Charlie?
The register lists 1 active mandates at Charlie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Charlie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →